Sellas Life Sciences announces pricing of $150 million underwritten public offering
SLS•Sellas Life Sciences Group priced an underwritten public offering of 11,538,462 shares at $13 per share, for gross proceeds of $150 million.
1. Offering priced
Sellas Life Sciences Group priced an underwritten public offering of 11,538,462 shares at $13 per share, totaling $150 million.




